91ÑÇÉ«

Antimicrobial resistance (AMR) is one of the greatest threats humanity faces today. Decades of use, overuse and misuse of antimicrobials in animals and humans has led to the development of bacteria, viruses, fungi and parasites that no longer respond to lifesaving antimicrobial medicines.

Now a new $8.7-million initiative, based at the  at 91ÑÇÉ«, will bridge science and policy to support evidence-informed AMR policymaking around the world. This initiative is led by 91ÑÇÉ« Professors  and  with support from leading 91ÑÇÉ« researchers Professors , ,  and University of Ottawa Professor .

The AMR Policy Accelerator is designed to advise the world’s governments, public health institutions and decision-makers on effective and equitable policies to ensure sustainable antimicrobial use for everyone. The AMR Policy Accelerator will undertake rigorous research, develop practical resources and tailor custom advisory services to comprehensively support equitable, evidence-informed policymaking on antimicrobial resistance at the national and global levels.

This initiative has been awarded $8.7 million from the , a leading charitable foundation that supports science to solve the urgent health issues facing everyone. To find out more about the AMR Policy Accelerator, visit .

About the Global Strategy Lab: Using an intensely interdisciplinary approach, GSL undertakes innovative research to advise governments and public health organizations on how to design laws, policies and institutions that address transnational health threats and make the world a healthier place for everyone.

Based at 91ÑÇÉ« and the University of Ottawa, GSL’s research division focuses on three streams: antimicrobial resistance, global legal epidemiology and public health institutions. GSL’s policy division provides specialized evidence-based advisory services to governments and civil society organizations. For more information, visit .

Originally published by .

You may also be interested in...